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ABSTRACT 
Tamaka Shwasa is one of the stressful medical conditions of today’s era and is well known for 
its episodic and chronic course which afflicts the human race. It is analogous to Bronchial 
Asthma due to similarity in etiopathogenesis and symptoms. Though incidence of Tamaka 
Shwasa is increasing in day to day practice and at alarming rate but very few patients need 
intensive care and most of the patients can be managed effectively by Ayurvedic line of 
treatment. Ayurvedic medicine may help to decrease the recurrence, improve immunity, and 
check symptoms naturally.  
Aims and Objectives: To evaluate the efficacy of Shringyadi Churna and Guduchyadi Kwatha in 
the management of Tamaka Shwasa. 
Materials and Methods: 20 Patients suffering from Tamaka Shwasa and attending the O.P.D. 
and I.P.D. department of Kayachikitsa, Rishikul Campus Haridwar were selected randomly. 
Patients were investigated as per proforma prepared for the study. Shringyadi Churna is given 
with Guduchyadi Kwatha as Anupana dravya for duration of 4 weeks, with assessment follow 
ups of 15 days interval and follow up was done after 2 months of the completion of the trial. All 
the patients were kept under strict dietary control during the treatment.  
Results and Discussion: The observation of the effect of therapy was encouraging and reduced 
recurrence significantly. Out of 20 patients, 16 patients i.e. 80% patients attained Marked 
Improvement in the symptoms, 1 patient i.e. 5% attained Moderate improvement in symptoms 
whereas In 3 patients i.e. 15% attained Complete remission of the symptoms of Tamaka 
Shwasa. 
KEYWORDS: Shringyadi Churna, Guduchyadi Kwatha, Tamaka Shwasa, Bronchial Asthma, 
Ayurveda, Aam, Agni. 
INTRODUCTION
Tamaka Shwasa is one of the five types of 
disease Shwasa. It is mainly a disease of 
Pranavahasrotas[1]. The signs, symptoms and 
etiopathogenesis of Bronchial Asthma explained in 
modern science have a lot of similarities with the 
disease entity Tamaka Shwasa. The main features of 
Bronchial Asthma are recurrent episodes of 
breathlessness, chest tightness, wheezing and cough. 
The prevalence of respiratory disorders like 
Tamaka Shwasa (Bronchial asthma) is now a day’s 
increasing alarmingly due to excessive pollution, 
overcrowding, occupational conditions, stress and poor 
hygiene etc. Both Ayurveda and modern medical 
Science agree regarding the Nidana of the disease as 
host factors (Nija Hetus-Dosha dushti and Ama) and 
Environmental factors (Agantuj Hetus - Raja, Dhuma, 
Pragvata, etc). It can be easily correlated with allergic 
condition. Nidana Parivarjan hence plays a key role in 
the management strategy in both sciences [2]. 
Bronchial Asthma is a major global health 
problem, which can affect the population irrespective 
of age, sex, economic status, etc. It is very common at all 
ages but predominantly in early life. Current estimates 
suggest that 300 million people worldwide suffer from 
asthma and an additional 100 million may be 
diagnosed with asthma by 2025[3]. Bronchial Asthma 
calls the attention of Medical world due to significant 
burden in terms of healthcare costs as well as lost 
productivity and reduced participation in family life.  
Acharya Charaka has mentioned that Tamaka 
Shwasa is Kapha-vataja vikar and site of its origin is 
Pitta sthana. “Kaphavatamkavetopittasthana-
samudbhava” [4] Tamaka Shwasa in general is described 
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as Yapya (palliable) disease. However in individual 
with recent origin of disease, person of Pravarabala or 
both said to be Sadhya[5]. Acharya Charaka has clearly 
mentioned the importance of Nidana parivarjana, and 
also the following principles for the management of 
Shwasa roga. ‘The medicine and dietetic regimen which 
controls the Kapha and Vata due to their Ushna guna 
and are Vatanulomaka in action must be utilized in the 
treatment of Shwasaroga”[6]. Brimhana is considered 
the best option compared to Shamana and Karshana 
when treating Tamaka Shwasa patient[7]. Also, any 
remedy which aggravates Vata and pacifies Kapha or 
which pacifies Vata and aggravates Kapha or which 
pacifies either Vatakapha or which pacifies only Vata 
should be used for the management of Tamaka 
Shwasa[8]. 
The current management of Tamaka Shwasa 
(Bronchial Asthma) by modern medicine is only 
providing short term symptomatic relief but does not 
provide any long term relief to the patient. On the other 
hand prolonged use of these drugs are not safe, as it has 
many adverse effect with systemic manifestation and as 
the chronicity increases drug dose dependency 
increases & dilates the lung tissue to such an extent 
that at last it leads to respiratory failure. In present 
scenario Ayurveda is the best way to effectively & safely 
manage the condition without any drug dependency 
where various Shodhana procedures and use of 
internal medication not only detoxifies the body but 
also provides nutrition & increases the elasticity of lung 
tissue & develops natural immunity of the body. So 
with this aim present study was conducted to provide a 
unique, but accurate & effective method of dealing with 
the complexities of the disease. Thus decreasing 
episodic recurrence of the disease and providing long 
term relief to the patient. 
For the present study drug has been selected 
from Chakradatta Hikkashwasa-chikitsaprakarana[9]: 
Shringyadi Churna and Guduchyadi Kashaya. Drugs are 
selected as per the principles of Ayurveda and Research 
work conducted regarding these drugs in various 
research institutes. Drugs having Vatakaphahara, 
Ushna & Vatanulomaka property were selected & 
Compound preparation in the form of Churna & Kwatha 
was prepared. Contents of Shringyadi Churna are 
Karkatshringi, Shati, Pushkarmula, Maricha, Shunthi, 
Pippali, Mustaka and Sharkara in equal parts and 
contents of Guduchyadi Kwatha are Guduchi, Vasa, 
Bilwa, Agnimantha, Gambhari, Shyonaka & Patala (all 
contents in equal parts). 
After the evaluation of the trial, it has been 
proved that Shringyadi Churna with Guduchyadi 
Kwatha as Anupana dravya shown remarkably good 
results, in pacifying the symptoms and reducing the 
recurrence and frequency of episodes in the patients of 
Tamaka Shwasa. 
 
 
MATERIAL & METHODS 
Aims and Objectives 
The present study has been undertaken with the 
following aims and objectives. 
 To study the aetiopathogenesis of Tamaka Shwasa. 
 To evaluate the efficacy of Shrigyadi Churna & 
Guduchyadi Kwatha as Anupana dravya in the 
management of Tamaka Shwasa. 
 To identify the best and effective treatment for the 
management of Tamaka Shwasa. 
Selection of patients 
Total 20 Patients of Tamaka Shwasa were 
selected from the O.P.D./I.P.D. of P.G. Dept. of 
Kayachikitsa, Rishikul Campus, Haridwar on the basis 
of inclusion and exclusion criteria, depending on the 
detailed clinical history, physical examination and 
other necessary / desired investigations and 
irrespective of their gender, caste or creed. 
Selection of Sample: Randomized sampling 
Type of study: Single Blind 
Drug trial schedule: Patients were treated with 
Shringyadi Churna 5 gm b.d. and Guduchyadi Kwatha 40 
ml as Anupana Dravya 1 hour before meal. 
Inclusion Criteria 
 Presence of symptoms of airflow obstruction (2 or 
more of cough, wheezing, dyspnoea). 
 Airflow obstruction is atleast partially reversible. 
 Oxygen saturation > 90% 
 Cases included from intermittent, mildly 
persistent to moderate persistent asthma. 
 PEFR 100 – 300 ml/min = Moderate Exacerbation. 
 Age18-70 years. 
Exclusion Criteria 
 PEFR < 100 litre/min = Severe Exacerbation 
(Status Asthmaticus). 
 Oxygen saturation <90% 
 Chronicity more than 10 years. 
 Asadhya Lakshanas of Tamaka Shwasa 
 The patient with H/O Tuberculosis, COPD, 
Emphysema, Chronic airway obstruction, H/O 
Cardiac involvement.  
 H/O Endocrine disorders like diabetes mellitus, 
thyroidism. 
 Other complicated respiratory diseases having 
any organic lesion such as tumor or any 
anatomical defect in airway. 
 If the patient exhibits short seasonal changes of 
less than 4 weeks duration. 
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 Any other physical and surgically ill patient will 
be excluded 
Criteria for withdrawal 
(1) Personal matters   
(3) Aggravation of complaints 
(2) Intercurrent illness   
(4) Any other difficulties 
(5) Leave against medical advice (LAMA) 
Diagnostic Criteria 
An extensive proforma was compiled on the 
basis of classical signs and symptoms of the Tamaka 
Shwasa as per the Ayurveda & modern classics. A 
detailed clinical history and respiratory examination 
was done and the data was collected. A complete 
history taking Dashvidh pariksha etc. of each patient 
was compiled and filled in proforma. All vital signs like 
B.P, Pulse Rate, Respiratory rate were noted and Peak 
Flow Meter reading. Breath holding time, Chest 
expansion was taken before and during treatment for 
assessment. 
Study Plan 
The treatment schedule is classified as follows 
No. of 
pt’s 
Drug Dose Duration 
20 Shringyadi 
Churna + 
Guduchyadi 
Kashaya 
5 gm Churna 
twice in a day 
with 40 ml 
Kwatha as 
Anupana dravya 
 2 months 
Criteria for assessment 
The assessment of the trial was done on the basis of 
following parameters: 
Subjective: The subjective assessment was done on the 
basis of improvement in signs and symptoms of 
Tamaka Shwasa described in classics, before during 
and at the end of the trial.  
Objective: The objective assessment was done on the 
basis of changes in clinical findings, relevant laboratory 
parameters and Pulmonary Function Test before 
during and at the end of the trial.  
Laboratory Investigations 
a. Haematological investigations after completion 
of treatment were repeated. 
b. Respiratory function tests were repeated before, 
during and at the end of trial. 
i) Peak Expiratory Flow Rate 
ii) Breath holding time 
iii) Chest Expansion 
For the signs and symptoms of the disease 
Tamaka Shwasa, grading was done depending upon the 
severity and assessment was done on the following 
Lakshanas graded. 
All the signs & symptoms were given scores 
depending upon their severity before, during and at the 
end study. They are as follows: 
1. Frequency of Shwasa Vega 
0 : No attack during 15 days 
1 : 1 – 5 attack during 15 days 
2 : 6 - 10 attack during 15 days 
3 : 11 – 15 attack during 15 days 
4 : > 15 attack during 15 days 
2. Intensity and Duration of attack 
0 : No attack 
1 : Attack lasting 10 mins, resolution without 
medication. 
2 : Attack lasting ½ hour resolution without 
medication. 
3 : Attack lasting ½ hour resolution with 
Ushnopchara. 
4 : Attack lasting more than ½ hour resolution 
only after medication. 
3. Number of Emergency medicine taken 
0 : None 
1 : Occasionally during attack 
2 : Regular Oral / Inhaler 
3 : Regular Oral + Inhaler 
4 : Regular Oral + Inhaler + Occasional injectibles 
 CARDINAL SYMPTOMS 
4. Shwasakrichhata 
0 : No sign of Shwasakrichhata 
1 : Slight Shwasakrichhata after heavy work 
2 : Shwasakrichhata on slight exertion like 
walking 
3 : Shwasakrichhata even at rest 
4 : Very severe Shwasakrichhata and require 
medication / hospitalization. 
5. Kasa 
0 : No Kasa 
1 : Kasavega sometimes but is not troublesome 
2 : Troublesome Kasa, but do not disturb the sleep 
3 : Very troublesome Kasa, does not even allow to 
sleep 
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6. Pinasa 
0 : No Pinasa 
1 : Pinasa along with attack 
2 : Pinasa even without attack  
3 : Pinasa always persisting 
7. Parshvashula 
0 : No Parshvashula 
1 : Parshvashula along with the attack 
2 : Very often Parshvashula even without attack 
3 : Always Parshvashula 
8. Ghurghurukam (Wheezing) 
0 : No Wheezing 
1 : Wheezing only at night 
2 : Wheezing at night and occasionally during 
day time 
3 : Wheezing throughout the day 
9. Kaphanishthivana 
0 : No Kaphanishthivan 
1 : Occasional Kaphanishthivan 
2 : Very often Kaphanishthivan 
3 : Always Kaphanishthivan 
10. Rhonchi 
0 : Absence of Rhonchi on normal breathing & 
deep breathing. 
1 : Absent on normal breathing but few rhonchi 
on forced breathing. 
2 : A few scattered bilateral rhonchi on normal / 
deep breathing. 
3 : Innumerable high pitched bilateral rhonchi on 
normal / deep breathing.  
11. Crepitation 
0 : Absence of crepitation on normal breathing & 
deep breathing 
1 : Absent on normal breathing but few crepts on 
forced breathing. 
2 : A few scattered bilateral crepts on normal / 
deep breathing 
3 : Innumerable high pitched bilateral crepts on 
normal / deep breathing.  
Follow up study 
After the completion of the treatment, the 
follow up study was done after two months to note the 
recovery of attacks and symptoms. 
Criteria for the total effect of the therapy 
To assess the total effect of the therapy, the 
following criteria were fixed to each of the status. 
Complete 
Remission 
 
100% relief in signs and symptoms. 
No attack of Shwasavega during and 
after the treatment upto two months 
of follow up. 
Markedly 
Improved 
 
More than 75% relief in signs and 
symptoms, with the frequency and 
intensity of attack reduced to 75% of 
the initial one. 
Moderately 
Improved 
 
50% to 75% relief in signs and 
symptoms, with the frequency and 
intensity of attack reduced to 50% of 
the initial one. 
Mildly 
Improved 
 
25% to 50% relief in signs and 
symptoms, with the frequency and 
intensity of attack reduced to 25% of 
the initial one. 
Unchanged 
 
Less than 25% relief in signs and 
symptoms, with no change in the 
frequency and intensity of attack. 
Statistical Analysis 
The information collected on the basis of 
observation made during the treatment are analyzed 
on a statistical criteria in terms of mean score (X), 
standard deviation (S.D.), Standard error (S.E.), Paired t 
test was carried at the level of 0.05, 0.01, 0.001, of p 
level thus the obtained results were interpreted as: 
P> 0.05 Unimprovement 
P< 0.05 Improvement 
P< 0.01 Significant Improvement 
P< 0.001 Highly significant 
To, more specifically quantify the percentage of 
improvement in each patient, this was also calculated 
using the formula (BT – AT) * 100 / BT. 
RESULTS AND DISCUSSION 
 The observations made on 20 patients of Tamaka 
Shwasa showed that maximum patients were 
belonging to the age group of 21-30, 31-40, and 
51-60 yrs, were male, were married, of Hindu 
religion, belong to urban habitat, were serving in 
some services and were from lower middle class. 
In most of the patients Bowel habit was regular, 
Sleep pattern was disturbed. 
 Maximum number of patients showed positive 
family history, Extrinsic type of Asthma, with 
chronicity of < 2 yrs and > 15 yrs and mostly don’t 
do exercise except their routine work. Tobacco 
chewing was present as addiction in maximum 
patients and aggravation of attacks occurs more in 
winters. In maximum patients Moderate 
persistent asthma was present with PEFR b/w 
151-250 L/min. 
 Maximum patients have Vata-kaphaj as Deha 
prakritiand Tamasa as Manasa prakriti, Madhyam 
Sara, Sanh anana, Satmya & Vyayama Shakti and 
Avara Satva, Abhyavharan Shakti & Jaran Shakti. 
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Vishamashana as Aahara vidhi and had shown 
more indulgence in Madhura rasa. 
 Pinasa as Nidanarthkara roga, excessive usage of 
Sheetambu and exposure to Dhooma was found to 
be the etiological factor in maximum patients. In 
most of the patients Sashabdashwasa was present 
as Pranavaha srotodushti lakshana, Oshthashosha 
as Udakvaha srotodushti lakshana and Avipaka as 
Annavaha sroto dushti lakshan. 
 Among Cardinal Symptoms all 20 patients 
reported the symptom of Shwasakrichhata, 
Pinasa, & Ghurghurukam. 19 patients reported the 
presence of Kasa and Kaphanishthivana. Only 17 
patients reported the presence of Parshvashula.  
Effect of Shringyadi Churna & Guduchyadi Kwatha on the Cardinal symptoms of Tamaka Shwasa 
No. of 
patients 
Cardinal 
Symptoms 
 Mean Score ± S.D % Relief t P 
BT A1 A2 A3 A4 
20 Shwasakricchata 3.3±0.80 1.6±0.77 0.6±0.76 0.2±0.78 0.1±0.76 96.96% 19.10 < 0.001 
19 Kasa 2.65±1.04 1.05±1.12 0.35±1.09 0.2±1.01 0.05±1.07 98.11% 10.86 < 0.001 
20 Pinasa 3.3±0.57 0.7±1.00 0.35±0.97 0.2±1.15 0.15±1.12 95.45% 12.59 < 0.001 
17 Parshvashula 1.5±0.95 0.4±0.99 0.3±1.03 0.15±1.06 0.1±1.02 93.33% 6.15 < 0.001 
20 Ghurghurukam 2.85±0.87 0.65±0.96 0.35±0.84 0.1±0.56 0.1±0.56 96.49% 21.8 < 0.001 
19 Kaphanishthivan 2.45±0.99 1.05±1.16 0.45±1.22 0.25±1.21 0.1±1.10 95.91% 9.48 < 0.001 
Cardinal Symptoms: In 20 patients of Tamaka Shwasa, Highly Significant (p< 0.001) result was obtained on all the 
cardinal symptoms after using Shringyadi Churna & Guduchyadi Kwatha as Anupana dravya. There was 98.11% 
relief in Kasa. The main symptom Shwaskrichhata was relieved upto 96.96%. The symptom of Ghurghurukam was 
reduced upto 96.49%. There was relief in Kapha nishthivana upto 95.91%. There was 95.45% relief in Pinasa and 
the reduction in Parshvashula was upto 93.33%.  
Effect of Shringyadi Churna & Guduchyadi Kwatha on various assessment parameters 
Assessment 
Parameters 
 
N 
Mean Score ± S.D % Relief T P 
BT A1 A2 A3 A4 
No. of emergency 
medicine taken 
20 1.95±1.60 0.35±1.3 0.25±1.47 0.2±1.5 0.15±1.5 92.30% 5.37 < 0.001 
Intensity & 
duration of 
attack 
20 3.55±0.69 1.9±1.06 0.6±0.74 0.4±0.63 0.25±0.59 92.95% 24.7 < 0.001 
Frequency of 
Shwasa vega 
20 3.9±0.31 2±0.86 0.6±0.65 0.45±0.6 0.25±0.59 93.58% 27.3 < 0.001 
Rhonchi 20 3±0 1±0.97 0.35±0.49 0.35±0.4 0.2±0.41 93.33% 29.8 < 0.001 
Crepitation 20 0.7±0.86 0.35±0.49 0.2±0.69 0.15±0.6 0±0.8 100% 3.59 < 0.01 
SpO2% 20 95.6±0.75 97.2±1.30 97.45±1.08 97.5±0.9 98.05±0.84 2.56% 13.0 < 0.001 
PEFR(L/min) 20 265.5±115.87 286.5±23.20 301.5±25.46 324.5±35.7
2 
358±47.78 34.83% 8.65 < 0.001 
Chest expansion 
(cms.) 
20 4.2±1.47 4.65±0.33 5.22±0.69 5.65±0.80 6.48±0.73 54.28% 13.89 < 0.001 
Breath holding 
time (/min) 
20 29.5±8.87 33±4.95 41±3.75 47.5±6.02 54±6.11 83.05% 17.91 < 0.001 
Respiratory Rate 20 23.05 ±1.35 19.6±1.57 18.95±1.41 18.7±1.34 16.85±1.81 27.11% 15.29 < 0.001 
ESR 20 33±23.03 23.65±10.76 19.45±12.20 17.6±14.21 11.7±17.59 64.54% 5.412 < 0.001 
AEC 20 352.6±165.5 234.5±184.36 195.7±153.09 230.25±15
6.34 
167.9±176.5
4 
52.38% 4.68 < 0.001 
Above table reveals that in 20 patients of 
Tamaka Shwasa Highly Significant (p< 0.001) result 
was obtained on various assessment parameters except 
crepitation where significant result (p<0.01) is 
obtained after using Shringyadi Churna & Guduchyadi 
Kwatha as Anupana dravya. as Number of Emergency 
medicine taken was reduced upto 92.30 %. The 
Intensity & duration of attack was reduced by 92.95 %. 
The frequency of attack was reduced by 93.58 %. The 
relief in Rhonchi was 93.33%. SpO2% was increased by 
2.56 %. There was an increase in PEFR by 34.83 %. The 
relief in Crepitation was 100 %.  
There was an increase in B.H.T by 83.05 %. 
There was an increase in chest expansion by 54.28%. 
Among Biophysical parameter: The Respiratory rate 
was decreased by 27.11 %. Among Haematocrit values : 
The level of ESR was reduced by 64.54%. The level of 
AEC was reduced by 52.38%. 
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OVERALL EFFECT OF THERAPY ON 20 PATIENTS OF 
TAMAKASHWASA 
Status  Complete 
remission 
Markedly 
improved 
Moderately 
improved 
Mildly 
improved 
Unchanged 
No. of 
patients 
3 16 1 0 0 
% 15% 80% 5% 0 0 
Out of 20 patients 3 patients i.e. 15% patients 
attained Complete remission of the symptoms. 16 
patients i.e. 80% patients attained Marked 
Improvement in the symptoms whereas only 1 patient 
i.e. 5% attained Moderate Improvement in the 
symptoms of Tamaka Shwasa. 
FOLLOW- UP WISE DISTRIBUTION OF PATIENTS 
Follow up of patients on 
completion of trial after 
2 months 
No. of patients reported to 
have recurrence of the 
disease Tamaka Shwasa 
10 0 
Out of 20 patients, only 10 patients came for 
follow up and reported not any recurrence of the 
symptoms since last 2 months. 
The difference in the distribution of the 
contents of Shringyadi Churna and Guduchyadi Kwatha 
has brought the above result which clearly indicates 
Statistically that, on many symptoms and assessment 
parameters combination has shown the admirable 
results. This data ascertains the effectiveness of 
synergistic effect of Shringyadi churna along with 
Guduchyadi Kashaya as Anupanadravya.  
The probable mode of Action of the drug can be 
discerned from the results. 
Shringyadi Churna 
The Shaman yoga in Shwasa is expected to 
work on Prana-udaka and Annavahasrotasa and should 
provide Dipana- Pachana, Vatanulomana, 
Vatakaphahara property. Here Karkatshringi is 
Kaphanissaraka–kaphaghna and Katupaushtika in 
nature. Pushkarmula is Kaphavata shamaka, Ushna 
virya and Katupaushtika in nature having Dipana-
Pachana and Vatanulomana guna. Shati is Kapha-vata 
shamaka, Ushna virya and having the property of 
Dipana, Rochana and Shool prashamana. Shunthi is 
Kaphaghna and Ushnavirya. Maricha is having 
Kaphagna and Kaphanissaraka guna. Pippali is 
Kaphavata shamaka and Agnivardhini. Sharkara is 
Sheet virya, Balya and Poshaka in nature. All these 
Characteristics made these drugs to act on Prana - 
Udaka and Annavaha srotasa so that the Samprati 
vighatana occurs in a systemic manner starting from 
the Aamashaya where the Dipana-pachana and 
Agniguna of these drugs helps in the Pachana of Ama in 
the body. Also Kaphaghna and Kaphanissaraaka guna 
will helps in the removing of blocked channels of the 
body i.e. Srotorodha will be cured and Vatanulomana 
will be achieved so that the Kupitavata will attain its 
Samyaka state and there will be relief in the symptoms 
of Tamaka Shwasa. Balya guna of these medicines on 
the other hand will prevent the Prakopa of Vayu which 
may occur due to continuous use of Kapahnashak & 
Kaphanissaraka aushadh.  
Guduchyadi Kwatha 
Most of the contents of Guduchyadi Kwatha are 
having Katu, Tikta Rasa, Ushna Virya, Katu vipaka and 
Kapha-vatghna property which seems to be quite 
effective in antagonizing the Shwasa roga, which is 
Kapha-vata pradhana disease. Quick absorption of the 
Kwatha from Aamashaya due to its Vikasi and Vyavayi 
guna also contribute to the quick implementation of its 
action. Here Vasa possess the property of Kapha 
nissaraka & Kaphaghna. Guduchi is Kaphghna Vrishya & 
Rasayana. Bilwa is Kaphavata shamak, Ushna Virya 
having Pachana and Balya guna. Agnimanth is 
Kaphaghna, Dipana-pachana and Anulomana. Shyonaka 
is Kaphaghna, Dipana-pachana, Katupaushtika, 
Shothahara & Vedana sthapana. Patala is Tridosha 
shamak & Ushnavirya. Gambhari is Balya, Sandhaniye, 
Rasayana & Vedana sthapana. All these drugs act on the 
Pranavaha-udakavaha and Annavahasrotas and helps 
in relieving the symptoms. The elimination of Kapha 
will release the obstruction and free flow of Pranavayu 
will be revealed in the form of improvement. Here 
inhalation of the vapours which comes during the 
preparation of decoction will work locally on the upper 
& lower respiratory tract thereby increasing the 
circulation of blood, relieve in inflammation thereby in 
bronchoconstriction and Ultimately the broncho-
dilatation which will bring free flow of Pranavayu.  
The pharmacological studies already reported 
on the individual drugs, also favours the effectiveness 
of various contents of Shringyadi Churna and 
Guduchyadi Kwatha in disease Bronchial Asthma as 
given below [10] 
Anti-allergic: Guduchi, Karkatshringi, Shati. 
Anti-inflammatory: Guduchi, Maricha, Pippali, Shunthi, 
Bilwa, Karaktshringi, Pushakarmula, Shyonaka, 
Agnimantha, Patala, Gambhari. 
Anti-spasmodic: Vasa, Karkatshringi, Shati, Bilwa, 
Shyonaka, Pippali, Maricha. 
Bronchodilator: Vasa, Pippali, Shati, Pushkarmula 
Expectorant: Vasa, Karkatshringi, Shati, Patala 
Immunomodulator: Pippali, Guduchi 
Anti-Oxidant: Shunthi, Maricha 
CONCLUSION 
In nut shell it can be concluded that: 
1. In present era, the most common etiological factors 
for Tamaka Shwasa are derived from Polluted 
Environment, unhealthy dietary habits and familial 
disposition as evident from the study. 
2. The etiological factors are affecting the Agni and 
Pranavahasrotas. 
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3. The optimum result has been seen by the usage of 
drugs which clears the Srotovrodha by optimizing 
the Agni. Shringyadi Churna & Guduchyadi Kwatha 
is such a drug here. 
4. Results of this work have undoubtedly established 
the importance of synergistic effect of Shringyadi 
Churna & Guduchyadi Kwatha. In future, 
researchers may try to study the efficacy of the 
drug by increasing the follow up period so that the 
absence of recurrence of the disease can be 
ascertained for more duration. It can be concluded 
that the study scientifically proves the efficacy of 
traditionally practiced Shringyadi Churna & 
Guduchyadi Kwatha in the management of Tamaka 
Shwasa. 
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